# Follow-up Trial of Rituximab Interferon Transplant Trial: Study Drug-Rituximab and Alpha Interferon

> **NCT03087929** · — · COMPLETED · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 12 (actual)

## Conditions studied

- Lymphoma, Follicular

## Interventions

- **OTHER:** Follow up

## Key facts

- **NCT ID:** NCT03087929
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09-20
- **Primary completion:** 2017-03-15
- **Final completion:** 2017-03-15
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03087929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03087929, "Follow-up Trial of Rituximab Interferon Transplant Trial: Study Drug-Rituximab and Alpha Interferon". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03087929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*